Erythroferrone inhibits the induction of hepcidin by BMP6

Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization

Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · see citing works

Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis

Makker, J. S., Hanif, A., Bajantri, B., & Chilimuri, S. S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,353 · see citing works

Identification of erythroferrone as an erythroid regulator of iron metabolism

Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127 · see citing works

Hepcidin and iron regulation, 10 years later

Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962 · see citing works

Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter

Korchynskyi, O., & ten Dijke, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111023200 · Cited by 876 · see citing works

BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism

Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769 · see citing works

Lack of the bone morphogenetic protein BMP6 induces massive iron overload

Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., & Roth, M.-P. (2009) · Nature Genetics · doi:10.1038/ng.320 · Cited by 587 · see citing works

Suppression of hepcidin during anemia requires erythropoietic activity

Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472 · see citing works

Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors

Cuny, G. D., Yu, P. B., Laha, J. K., Xing, X., Liu, J.-F., Lai, C. S. C., Deng, D. Y., Sachidanandan, C., Bloch, K. D., & Peterson, R. T. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.052 · Cited by 343 · see citing works

Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin

Aschemeyer, S., Qiao, B., Stefanova, D., Valore, E. V., Sek, A. C., Ruwe, T. A., Vieth, K. R., Jung, G., Casu, C., Rivella, S., et al. (2018) · Blood · doi:10.1182/blood-2017-05-786590 · Cited by 325 · see citing works

Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis

Vokurka, M., Krijt, J., Šulc, K., & Nečas, E. (2006) · Physiological Research · doi:10.33549/physiolres.930841 · Cited by 263 · see citing works

Structural insights into BMP receptors: Specificity, activation and inhibition

Yadin, D., Knaus, P., & Mueller, T. D. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.11.005 · Cited by 221 · see citing works

Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin

Ashby, D. R., Gale, D. P., Busbridge, M., Murphy, K. G., Duncan, N. D., Cairns, T. D., Taube, D. H., Bloom, S. R., Tam, F. W. K., Chapman, R., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.013136 · Cited by 191 · see citing works

Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6

Canali, S., Wang, C., Zumbrennen‐Bullough, K. B., Bayer, A., & Babitt, J. L. (2017) · American Journal of Hematology · doi:10.1002/ajh.24888 · Cited by 133 · see citing works

Immunoassay for human serum erythroferrone

Ganz, T., Jung, G., Naeim, A., Ginzburg, Y., Pakbaz, Z., Walter, P. B., Kautz, L., & Nemeth, E. (2017) · Blood · doi:10.1182/blood-2017-04-777987 · Cited by 125 · see citing works

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice

Nai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., Gineste, A., Latour, C., Besson-Fournier, C., Lin, H. Y., et al. (2016) · Blood · doi:10.1182/blood-2015-11-681494 · Cited by 97 · see citing works

Anemia, Ineffective Erythropoiesis, and Hepcidin: Interacting Factors in Abnormal Iron Metabolism Leading to Iron Overload in β-Thalassemia

Gardenghi, S., Grady, R. W., & Rivella, S. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.003 · Cited by 96 · see citing works

Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice

Wang, C., Core, A. B., Canali, S., Zumbrennen‐Bullough, K. B., Özer, S., Umans, L., Zwijsen, A., & Babitt, J. L. (2017) · Blood · doi:10.1182/blood-2016-12-759423 · Cited by 86 · see citing works

Hepcidin is regulated by promoter-associated histone acetylation and HDAC3

Pasricha, S., Lim, P. J., Duarte, T. L., Casu, C., Oosterhuis, D., Mleczko‐Sanecka, K., Suciu, M., da Silva, A. R., Al-Hourani, K., Arezes, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00500-z · Cited by 65 · see citing works

Erythroferrone and matriptase‐2 independently regulate hepcidin expression

Aschemeyer, S., Gabayan, V. R., Ganz, T., Nemeth, E., & Kautz, L. (2017) · American Journal of Hematology · doi:10.1002/ajh.24672 · Cited by 30 · see citing works

Induced Disruption of the Iron-Regulatory Hormone Hepcidin Inhibits Acute Inflammatory Hypoferraemia

Armitage, A. E., Lim, P. J., Frost, J. N., Pasricha, S.-R., Soilleux, E. J., Evans, E., Morovat, A., Santos, A., Diaz, R., Biggs, D., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000447713 · Cited by 20 · see citing works

Iron homeostasis and oxidative stress: An intimate relationship

Galaris, D., Barbouti, A., & Pantopoulos, K. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118535 · Cited by 922 · see citing works

Mechanisms controlling cellular and systemic iron homeostasis

Galy, B., Conrad, M., & Muckenthaler, M. U. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00648-1 · Cited by 806 · see citing works

Iron metabolism and iron disorders revisited in the hepcidin era

Camaschella, C., Nai, A., & Silvestri, L. (2020) · Haematologica · doi:10.3324/haematol.2019.232124 · Cited by 734 · see citing works

Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects

Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724 · see citing works

Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis

Yu, Y., Jiang, L., Wang, H., Shen, Z., Cheng, Q., Zhang, P., Wang, J., Wu, Q., Fang, X., Duan, L., et al. (2020) · Blood · doi:10.1182/blood.2019002907 · Cited by 601 · see citing works

Iron metabolism: pathophysiology and pharmacology

Roemhild, K., von Maltzahn, F., Weiskirchen, R., Knüchel, R., von Stillfried, S. F., & Lammers, T. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.05.001 · Cited by 315 · see citing works

The multifaceted role of iron in renal health and disease

van Swelm, R. P. L., Wetzels, J. F. M., & Swinkels, D. W. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0197-5 · Cited by 279 · see citing works

Hepcidin and Anemia: A Tight Relationship

Pagani, A., Nai, A., Silvestri, L., & Camaschella, C. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01294 · Cited by 256 · see citing works

The mechanism of ferroptosis and its related diseases

Feng, S., Tang, D., Wang, Y., Li, X., Bao, H., Tang, C., Dong, X., Li, X., Yang, Q., Yan, Y., et al. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00142-2 · Cited by 224 · see citing works

Basics and principles of cellular and systemic iron homeostasis

Katsarou, A., & Pantopoulos, K. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100866 · Cited by 220 · see citing works

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

Babitt, J. L., Eisenga, M. F., Haase, V. H., Kshirsagar, A. V., Levin, A., Locatelli, F., Małyszko, J., Swinkels, D. W., Tarng, D., Cheung, M., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.03.020 · Cited by 222 · see citing works

Hypoxia-inducible factor–prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease

Haase, V. H. (2021) · Kidney International Supplements · doi:10.1016/j.kisu.2020.12.002 · Cited by 203 · see citing works

Erythroferrone structure, function, and physiology: Iron homeostasis and beyond

Srole, D. N., & Ganz, T. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30247 · Cited by 155 · see citing works

A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis

Bell, S., Rigas, A. S., Magnússon, M. K., Ferkingstad, E., Allara, E., Björnsdóttir, G., Ramond, A., Sørensen, E., Halldorsson, G. H., Paul, D. S., et al. (2021) · Communications Biology · doi:10.1038/s42003-020-01575-z · Cited by 157 · see citing works

Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis—Mechanistic Insights into Anemia of Inflammation and Its Treatment

Lanser, L., Fuchs, D., Kurz, K., & Weiß, G. (2021) · Nutrients · doi:10.3390/nu13113732 · Cited by 166 · see citing works

Nrf2 controls iron homoeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin

Lim, P. J., Duarte, T. L., Arezes, J., Garcia-Santos, D., Hamdi, A., Pasricha, S.-R., Armitage, A. E., Mehta, H., Wideman, S., Santos, A. G., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0063-6 · Cited by 147 · see citing works

Iron, Neuroinflammation and Neurodegeneration

Ward, R. J., Dexter, D. T., & Crichton, R. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137267 · Cited by 140 · see citing works

The evaluation of iron deficiency and iron overload

Gattermann, N., Muckenthaler, M. U., Kulozik, A. E., Metzgeroth, G., & Hastka, J. (2021) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2021.0290 · Cited by 148 · see citing works

Hepcidin and the BMP-SMAD pathway: An unexpected liaison

Silvestri, L., Nai, A., Dulja, A., & Pagani, A. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.004 · Cited by 125 · see citing works

How I treat cancer-associated anemia

Gilreath, J. A., & Rodgers, G. M. (2020) · Blood · doi:10.1182/blood.2019004017 · Cited by 121 · see citing works

Hepcidin Therapeutics

Katsarou, A., & Pantopoulos, K. (2018) · Pharmaceuticals · doi:10.3390/ph11040127 · Cited by 115 · see citing works

Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets

Li, L.-X., Guo, F., Liu, H., & Zeng, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04239-9 · Cited by 112 · see citing works

Iron, glucose and fat metabolism and obesity: an intertwined relationship

Hilton, C., Sabaratnam, R., Drakesmith, H., & Karpe, F. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01299-0 · Cited by 113 · see citing works

Stress Erythropoiesis is a Key Inflammatory Response

Paulson, R. F., Ruan, B., Hao, S., & Chen, Y. (2020) · Cells · doi:10.3390/cells9030634 · Cited by 108 · see citing works

Erythroferrone lowers hepcidin by sequestering BMP2/6 heterodimer from binding to the BMP type I receptor ALK3

Wang, C., Xu, Y., Traeger, L., Dogan, D. Y., Xiao, X., Steinbicker, A. U., & Babitt, J. L. (2019) · Blood · doi:10.1182/blood.2019002620 · Cited by 100 · see citing works

Inherited Disorders of Iron Overload

Pantopoulos, K. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00103 · Cited by 98 · see citing works

Momelotinib: an emerging treatment for myelofibrosis patients with anemia

Chifotides, H. T., Bose, P., & Verstovšek, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01157-4 · Cited by 94 · see citing works

New insights into the links between hypoxia and iron homeostasis

Renassia, C., & Peyssonnaux, C. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000494 · Cited by 95 · see citing works

Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders

Xu, Y., Alfaro-Magallanes, V. M., & Babitt, J. L. (2020) · British Journal of Haematology · doi:10.1111/bjh.17252 · Cited by 94 · see citing works

Iron metabolism and iron deficiency anemia in women

Cappellini, M. D., Santini, V., Braxs, C., & Shander, A. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.08.014 · Cited by 102 · see citing works

Bone morphogenic proteins in iron homeostasis

Xiao, X., Alfaro-Magallanes, V. M., & Babitt, J. L. (2020) · Bone · doi:10.1016/j.bone.2020.115495 · Cited by 88 · see citing works

Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis

Watts, D., Gaete, D., Rodriguez, D., Hoogewijs, D., Rauner, M., Sormendi, S., & Wielockx, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218131 · Cited by 86 · see citing works

Hepcidin

Agarwal, A. K., & Yee, J. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.04.005 · Cited by 83 · see citing works

NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis

Duarte, T. L., Talbot, N. P., & Drakesmith, H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8148 · Cited by 77 · see citing works

Iron and liver cancer: an inseparable connection

Hino, K., Yanatori, I., Hara, Y., & Nishina, S. (2021) · FEBS Journal · doi:10.1111/febs.16208 · Cited by 68 · see citing works

The Importance of Iron Status for Young Children in Low- and Middle-Income Countries: A Narrative Review

Armitage, A. E., & Moretti, D. (2019) · Pharmaceuticals · doi:10.3390/ph12020059 · Cited by 71 · see citing works

Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia

Arezes, J., Foy, N., McHugh, K., Quinkert, D., Benard, S., Sawant, A., Frost, J. N., Armitage, A. E., Pasricha, S., Lim, P. J., et al. (2020) · Blood · doi:10.1182/blood.2019003140 · Cited by 68 · see citing works

Factors mediating exercise‐induced organ crosstalk

Sabaratnam, R., Wojtaszewski, J. F. P., & Højlund, K. (2022) · Acta Physiologica · doi:10.1111/apha.13766 · Cited by 69 · see citing works

Hepcidin and its therapeutic potential in neurodegenerative disorders

Qian, Z., & Ke, Y. (2019) · Medicinal Research Reviews · doi:10.1002/med.21631 · Cited by 63 · see citing works

Regulation of Iron Homeostasis and Related Diseases

Li, Y., Huang, X., Wang, J., Huang, R., & Wan, D. (2020) · Mediators of Inflammation · doi:10.1155/2020/6062094 · Cited by 64 · see citing works

New Insights Into Pathophysiology of β-Thalassemia

Sánchez‐Villalobos, M., Blanquer, M., Moraleda, J. M., Salido, E. J., & Pérez‐Oliva, A. B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.880752 · Cited by 62 · see citing works

The changing landscape of iron deficiency

Camaschella, C., & Girelli, D. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100861 · Cited by 66 · see citing works

Gain‐of‐function mutations in PIEZO1 directly impair hepatic iron metabolism via the inhibition of the BMP/SMADs pathway

Andolfo, I., Rosato, B. E., Manna, F., De Rosa, G., Marra, R., Gambale, A., Girelli, D., Russo, R., & Iolascon, A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25683 · Cited by 61 · see citing works

The critical roles of iron during the journey from fetus to adolescent: Developmental aspects of iron homeostasis

Donker, A. E., van der Staaij, H., & Swinkels, D. W. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100866 · Cited by 70 · see citing works

Cell‐type‐specific insights into iron regulatory processes

Mleczko‐Sanecka, K., & Silvestri, L. (2020) · American Journal of Hematology · doi:10.1002/ajh.26001 · Cited by 59 · see citing works

Iron metabolism and management: focus on chronic kidney disease

Agarwal, A. K. (2021) · Kidney International Supplements · doi:10.1016/j.kisu.2020.12.003 · Cited by 57 · see citing works

The opposing effects of acute inflammation and iron deficiency anemia on serum hepcidin and iron absorption in young women

Stoffel, N. U., Lazrak, M., Bellitir, S., Mir, N. E., Hamdouchi, A. E., Barkat, A., Zeder, C., Moretti, D., Aguenaou, H., & Zimmermann, M. B. (2019) · Haematologica · doi:10.3324/haematol.2018.208645 · Cited by 56 · see citing works

From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells

Grignano, É., Birsen, R., Chapuis, N., & Bouscary, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.586530 · Cited by 54 · see citing works

Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult β-thalassemia major

Casu, C., Chessa, R., Liu, A., Gupta, R., Drakesmith, H., Fleming, R., Ginzburg, Y. Z., MacDonald, B., & Rivella, S. (2020) · Haematologica · doi:10.3324/haematol.2018.212589 · Cited by 50 · see citing works

Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF

Wheeler, J. A., & Clinkenbeard, E. L. (2019) · Current Molecular Biology Reports · doi:10.1007/s40610-019-0110-9 · Cited by 48 · see citing works

Endothelial Bone Morphogenetic Protein 2 (Bmp2) Knockout Exacerbates Hemochromatosis in Homeostatic Iron Regulator (Hfe) Knockout Mice but not Bmp6 Knockout Mice

Xiao, X., Dev, S., Canali, S., Bayer, A. L., Xu, Y., Agarwal, A., Wang, C., & Babitt, J. L. (2019) · Hepatology · doi:10.1002/hep.31048 · Cited by 47 · see citing works

Shaping the bone through iron and iron-related proteins

Ledesma-Colunga, M. G., Weidner, H., Spasić, M. V., Hofbauer, L. C., Baschant, U., & Rauner, M. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.06.002 · Cited by 47 · see citing works

Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure

Robach, P., Gammella, E., Recalcati, S., Girelli, D., Castagna, A., Roustit, M., Lundby, C., Lundby, A., Bouzat, P., Vergès, S., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.233874 · Cited by 46 · see citing works

Managing the Dual Nature of Iron to Preserve Health

Silvestri, L., Pettinato, M., Furiosi, V., Volpe, L. B., Nai, A., & Pagani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043995 · Cited by 47 · see citing works

TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis

Ganz, T., Nemeth, E., Rivella, S., Goldberg, P., Dibble, A., McCaleb, M. L., Guo, S., Monia, B. P., & Barrett, T. D. (2023) · Advances in Therapy · doi:10.1007/s12325-022-02421-w · Cited by 44 · see citing works

Iron homeostasis during anemia of inflammation: a prospective study of patients with tuberculosis

Cercamondi, C. I., Stoffel, N. U., Moretti, D., Zöller, T., Swinkels, D. W., Zeder, C., Mhimibra, F., Hella, J., Fenner, L., & Zimmermann, M. B. (2021) · Blood · doi:10.1182/blood.2020010562 · Cited by 43 · see citing works

A fully human anti-BMP6 antibody reduces the need for erythropoietin in rodent models of the anemia of chronic disease

Petzer, V., Tymoszuk, P., Aßhoff, M., Carvalho, J. A., Papworth, J., Deantonio, C., Bayliss, L., Wake, M., Seifert, M., Brigo, N., et al. (2020) · Blood · doi:10.1182/blood.2019004653 · Cited by 44 · see citing works

Lactate modulates iron metabolism by binding soluble adenylyl cyclase

Liu, W., Zhang, S., Li, Q., Wu, Y. X., Jia, X., Feng, W., Li, Z. A., Shi, Y., Hou, Q., Ma, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.017 · Cited by 44 · see citing works

Effect of hepcidin antagonists on anemia during inflammatory disorders

Sagar, P., Angmo, S., Sandhir, R., Rishi, V., Yadav, H., & Singhal, N. K. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107877 · Cited by 43 · see citing works

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism

Ogawa, C., Tsuchiya, K., & Maeda, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033037 · Cited by 43 · see citing works

Iron deficiency and supplementation in heart failure

Lakhal‐Littleton, S., & Cleland, J. G. F. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-00988-1 · Cited by 44 · see citing works

Controversies on the Consequences of Iron Overload and Chelation in MDS

Vinchi, F., Hell, S., & Platzbecker, U. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000357 · Cited by 42 · see citing works

Melatonin: Potential avenue for treating iron overload disorders

Yang, J., Tang, Q., & Zeng, Y. H. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101717 · Cited by 41 · see citing works

Genome-wide meta-analysis of iron status biomarkers and the effect of iron on all-cause mortality in HUNT

Moksnes, M. R., Graham, S. E., Wu, K.-H., Hansen, A. F., Taliun, S. A. G., Zhou, W., Thorstensen, K., Fritsche, L. G., Gill, D., Mason, A. M., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03529-z · Cited by 40 · see citing works

Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease

Małyszko, J., Małyszko, J. S., & Matuszkiewicz‐Rowińska, J. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1599358 · Cited by 39 · see citing works

Iron overload and its impact on outcome of patients with hematological diseases

Franke, G., Kubasch, A. S., Cross, M. A., Vučinić, V., & Platzbecker, U. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100868 · Cited by 40 · see citing works

Fractalkine Induces Hepcidin Expression of BV-2 Microglia and Causes Iron Accumulation in SH-SY5Y Cells

Pandur, E., Tamási, K., Pap, R., Varga, E., Miseta, A., & Sipos, K. (2019) · Cellular and molecular neurobiology · doi:10.1007/s10571-019-00694-4 · Cited by 35 · see citing works

Iron Toxicity and Chelation Therapy in Hematopoietic Stem Cell Transplant

Isidori, A., Loscocco, F., Visani, G., Chiarucci, M., Musto, P., Kubasch, A. S., Platzbecker, U., & Vinchi, F. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2020.11.007 · Cited by 41 · see citing works

Coordination of iron homeostasis by bone morphogenetic proteins: Current understanding and unanswered questions

Fisher, A. L., & Babitt, J. L. (2021) · Developmental Dynamics · doi:10.1002/dvdy.372 · Cited by 38 · see citing works

Iron as a therapeutic target in chronic liver disease

Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i4.616 · Cited by 40 · see citing works

Leukemia inhibitory factor regulates Schwann cell proliferation and migration and affects peripheral nerve regeneration

Chen, Q., Liu, Q., Zhang, Y., Li, S., & Yi, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03706-8 · Cited by 37 · see citing works

Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice

Coffey, R., Jung, G., Olivera, J. D., Karin, G., Pereira, R. C., Nemeth, E., & Ganz, T. (2021) · Blood · doi:10.1182/blood.2021014054 · Cited by 37 · see citing works

Normal and dysregulated crosstalk between iron metabolism and erythropoiesis

Ginzburg, Y. Z., An, X., Rivella, S., & Goldfarb, A. N. (2023) · eLife · doi:10.7554/elife.90189 · Cited by 40 · see citing works

Regulation of iron homeostasis: Lessons from mouse models

Altamura, S., Marques, O., Colucci, S., Mertens, C., Alikhanyan, K., & Muckenthaler, M. U. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100872 · Cited by 35 · see citing works

Iron Deficiency, Anemia, and the Immune System

Mitterstiller, A., von Raffay, L., & Nairz, M. (2022) · Nutrition and health · doi:10.1007/978-3-031-14521-6_18 · Cited by 35 · see citing works

The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling

Sardo, U., Perrier, P., Cormier, K., Sotin, M., Personnaz, J., Medjbeur, T., Desquesnes, A., Cannizzo, L., Ruíz-Martínez, M., Thevenin, J., et al. (2024) · Blood · doi:10.1182/blood.2023022724 · Cited by 34 · see citing works

C-FGF23 peptide alleviates hypoferremia during acute inflammation

Agoro, R., Park, M. Y., Hénaff, C. L., Jankauskas, S. S., Gaias, A., Chen, G., Mohammadi, M., & Sitara, D. (2020) · Haematologica · doi:10.3324/haematol.2019.237040 · Cited by 33 · see citing works

Comparative analysis of oral and intravenous iron therapy in rat models of inflammatory anemia and iron deficiency

de Souza, L. V., Hoffmann, A., Fischer, C., Petzer, V., Aßhoff, M., Theurl, I., Tymoszuk, P., Seifert, M., Brigo, N., Hilbe, R., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.281149 · Cited by 33 · see citing works

Iron, erythropoietin, and inflammation regulate hepcidin in Bmp2‐deficient mice, but serum iron fails to induce hepcidin in Bmp6‐deficient mice

Wang, C., Canali, S., Bayer, A. L., Dev, S., Agarwal, A., & Babitt, J. L. (2018) · American Journal of Hematology · doi:10.1002/ajh.25366 · Cited by 32 · see citing works

Anemia de las enfermedades crónicas: fisiopatología, diagnóstico y tratamiento

Allende, R. D. L. C., de Entresotos, L. D., & Díez, S. C. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.07.035 · Cited by 34 · see citing works

Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosis

Sun, Y., Ren, Y., Song, L., Wang, Y.-Y., Li, T., Wu, Y., Li, L., & Yang, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116270 · Cited by 31 · see citing works

Impact of bacterial infections on erythropoiesis

de Souza, L. V., Hoffmann, A., & Weiß, G. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1841636 · Cited by 30 · see citing works

The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry

Castro-Mollo, M. W., Gera, S., Ruíz-Martínez, M., Feola, M., Gumerova, A. A., Planoutene, M., Clementelli, C., Sangkhae, V., Casu, C., Kim, S., et al. (2021) · eLife · doi:10.7554/elife.68217 · Cited by 30 · see citing works

Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial–mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway

Liu, D., Liu, J., Li, Y., Liu, H., Hassan, H. M., He, W., Li, M., Zhou, Y., Fu, X., Zhan, J., et al. (2021) · The Prostate · doi:10.1002/pros.24241 · Cited by 30 · see citing works

Deciphering the role of hepcidin in iron metabolism and anemia management

Kesharwani, P., Dash, D., & Koiri, R. K. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127591 · Cited by 33 · see citing works

Iron and Chronic Kidney Disease: Still a Challenge

Wojtaszek, E., Głogowski, T., & Małyszko, J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.565135 · Cited by 29 · see citing works

The mutual crosstalk between iron and erythropoiesis

Camaschella, C., Pagani, A., Silvestri, L., & Nai, A. (2022) · International Journal of Hematology · doi:10.1007/s12185-022-03384-y · Cited by 33 · see citing works

Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure

Ferreira, J. P., Anker, S. D., Butler, J., Filippatos, G., Januzzi, J. L., Schueler, E., Panova‐Noeva, M., Wetzel, K., Prochaska, J. H., Pocock, S., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.03.503 · Cited by 30 · see citing works

20 years of Hepcidin: How far we have come

Colucci, S., Marques, O., & Altamura, S. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.05.001 · Cited by 28 · see citing works

Metabolic regulation of stress erythropoiesis, outstanding questions, and possible paradigms

Ruan, B., & Paulson, R. F. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2022.1063294 · Cited by 29 · see citing works

The Role of Iron in Benign and Malignant Hematopoiesis

Sinha, S., Pereira-Reis, J., Guerra, A., Rivella, S., & Duarte, D. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8155 · Cited by 29 · see citing works

Hypobaric hypoxia regulates iron metabolism in rats

Li, Y., Zhou, Y., Zhang, D., Wu, W., Kang, X., Wu, Q., Wang, P., Liu, X., Gao, G., Zhou, Y., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28683 · Cited by 25 · see citing works

Iron Deficiency and Anemia Associated with Infectious and Inflammatory Diseases

Hoffmann, A., de Souza, L. V., & Weiß, G. (2022) · Nutrition and health · doi:10.1007/978-3-031-14521-6_17 · Cited by 27 · see citing works

Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease

Kurata, Y., Tanaka, T., & Nangaku, M. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000617 · Cited by 26 · see citing works

BMP5 contributes to hepcidin regulation and systemic iron homeostasis in mice

Xiao, X., Xu, Y., Moschetta, G. A., Yu, Y., Fisher, A. L., Alfaro-Magallanes, V. M., McMillen, S. A., Phillips, S., Wang, C., Christian, J. L., et al. (2023) · Blood · doi:10.1182/blood.2022019195 · Cited by 25 · see citing works

The BMP‐SMAD pathway mediates the impaired hepatic iron metabolism associated with the ERFE‐A260S variant

Andolfo, I., Rosato, B. E., Marra, R., Rosa, G. D., Manna, F., Gambale, A., Iolascon, A., & Russo, R. (2019) · American Journal of Hematology · doi:10.1002/ajh.25613 · Cited by 25 · see citing works

Mechanism and regulation of iron absorption throughout the life cycle

Qiu, L., Frazer, D. M., Hu, M., Song, R., Liu, X., Qin, X., Ma, J., Zhou, J., Tan, Z., Ren, F., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.01.002 · Cited by 29 · see citing works

Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial

Andersen, A. B., Bonne, T. C., Bejder, J., Jung, G., Ganz, T., Nemeth, E., Olsen, N. V., Huertas, J. R., & Nordsborg, N. B. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00070.2021 · Cited by 24 · see citing works

Maternal iron kinetics and maternal–fetal iron transfer in normal-weight and overweight pregnancy

Stoffel, N. U., Zimmermann, M. B., Cepeda-Lopez, A. C., Cervantes-Gracia, K., Llanas-Cornejo, D., Zeder, C., Tuntipopipat, S., Moungmaithong, S., Densupsoontorn, N., Lötscher, K. Q., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab406 · Cited by 24 · see citing works

Iron Mining for Erythropoiesis

Correnti, M., Gammella, E., Cairo, G., & Recalcati, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105341 · Cited by 27 · see citing works

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice

Nai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., Gineste, A., Latour, C., Besson-Fournier, C., Lin, H. Y., et al. (2016) · Blood · doi:10.1182/blood-2015-11-681494 · Cited by 97 · see citing works

Inactivation of Tmprss6 Hampers Hepcidin Inhibition By Erythroferrone through Upregulation of the BMP-SMAD Pathway

Silvestri, L., Nai, A., Campanella, A., Artuso, I., Bordini, J., & Camaschella, C. (2015) · Blood · doi:10.1182/blood.v126.23.408.408

Erythroferrone lowers hepcidin by sequestering BMP2/6 heterodimer from binding to the BMP type I receptor ALK3

Wang, C., Xu, Y., Traeger, L., Dogan, D. Y., Xiao, X., Steinbicker, A. U., & Babitt, J. L. (2019) · Blood · doi:10.1182/blood.2019002620 · Cited by 100 · see citing works

Iron, erythropoietin, and inflammation regulate hepcidin in Bmp2‐deficient mice, but serum iron fails to induce hepcidin in Bmp6‐deficient mice

Wang, C., Canali, S., Bayer, A. L., Dev, S., Agarwal, A., & Babitt, J. L. (2018) · American Journal of Hematology · doi:10.1002/ajh.25366 · Cited by 32 · see citing works

Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly

Gammella, E., Diaz, V., Recalcati, S., Buratti, P., Samaja, M., Dey, S., Noguchi, C. T., Gassmann, M., & Cairo, G. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00410.2014 · Cited by 59 · see citing works